Registration opens at 10.00h.
| Session 1 "Development and scalability of gene transfer vectors" | |
|---|---|
| 10:45 |
WELCOME K. Rübberdt, DECHEMA e.V., Frankfurt am Main/D |
| 10:50 |
KEYNOTE From the Virus to the Vector: Novel integrating Gene Therapy Vectors A. Schambach, Hannover Medical School, Hannover/D |
| 11:35 |
KEYNOTE Next generation AAV vectors for gene and cell therapy H. Büning, Hannover Medical School, Hannover/D |
| 12:20 |
Novel stable producer cell lines: enabling scalable lentiviral vector manufacturing A. S. Coroadinha, iBET and ITQB NOVA, Oeiras/POR |
| 12:45 |
Poster Talk: Development and evaluation of a serum-free manufacturing process for lentiviral vectors in industrial scale J. Dettmann, Miltenyi Biotec GmbH, Bergisch Gladbach/D |
| 13:00 | LUNCH |
| Session 2 "Strategies for vector optimization" | |
| 14:00 |
KEYNOTE Receptor-targeted viral vectors: rational design for in vivo gene delivery C. Buchholz, Paul-Ehrlich-Institut, Langen/D |
| 14:45 |
Optimizing transduction for clinical manufacturing of CAR-T and genetically modified CD34+ cells using Lentiviral vectors S. Hasenröder, Sirion Biotech GmbH, Planegg/D |
| 15:10 |
COFFEE BREAK |
|
Session 3 "Challenges in GMP Production of gene therapeutic products" | |
| 15:40 |
KEYNOTE From CAR T cells to CAR NK cells for improvement of cancer retargeting U. Köhl, Fraunhofer IZI, Leipzig/D |
| 16:25 |
KEYNOTE Manufacturing advances and scale-up for simple and complex ATMPs J. Campbell, Scottish National Blood Transfusion Center, Edinburgh/UK |
| 17:10 |
Analytical Preparedness to Support a Phase I Gene Therapy Product M. Joubert, Sanofi, Framingham, MA/USA |
|
17:35 - 20:00 |
GET-TOGETHER AT THE POSTERS |
18:00 - 19:00 Section Member Assembly of the DECHEMA Working Groups Cell Culture Technology and Medical Biotechnology (only for members)
Please click here to see the conference programm of 31 January 2019
Please click here to see the poster programme
